Related Experiment Video
Updated: Aug 8, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Unilateral uveitis induced by a nonionic iodinated contrast agent
Eveline Welzl-Hinterkörner1, Mark Haefner, Bernard Mengiardi
1Departments of Ophthalmology, City Hospital Triemli, Zurich, Switzerland. eveline.welzl@triemli.stzh.ch
Insights
Recurrent uveitis occurred in a lymphoma patient after contrast-enhanced computed tomography (CT) scans using iopamidol. This suggests iopamidol may trigger uveitis, potentially due to immune responses and prior radiation damage.
Area of Science:
- Ophthalmology
- Radiology
- Oncology
Background:
- A 44-year-old male with Stage I B mixed-cellularity Hodgkin lymphoma in remission.
- Patient received chemotherapy and radiotherapy for lymphoma.
- Underwent regular contrast-enhanced computed tomography (CT) scans for monitoring.
Observation:
- The patient experienced recurrent unilateral anterior uveitis, vitritis, and retinal bleedings.
- These ocular symptoms consistently appeared within hours after receiving intravenous iopamidol for CT scans.
- Symptoms resolved within a week with topical corticosteroid treatment.
Findings:
- Recurrent unilateral uveitis was observed following iopamidol-enhanced CT scans.
- The contrast agent iopamidol was administered intravenously (150 ml).
- The patient had a history of treated lymphoma.
Implications:
- Iopamidol may induce uveitis in susceptible individuals.
- A potential mechanism involves the interplay of immunologic responses and pre-existing vascular damage from radiation therapy.
- Highlights the importance of considering contrast agent-induced ocular inflammation in patients with a history of cancer treatment.
Purpose:
To report recurrent unilateral uveitis after computed tomography (CT) enhanced by the contrast agent iopamidol.
Design:
Observational case report.
Methods:
A 44-year-old man with a history of mixed-cellularity Hodgkin lymphoma, Stage I B (axillar, infraclavicular, subpectoral lymphomas) was under remission after chemotherapy and radiotherapy. The contrast-enhanced CT scans performed every 3 months were within hours followed by a marked unilateral anterior uveitis, vitritis, and retinal bleedings. Symptoms resolved with topical corticosteroid treatment within a week.
Results:
We observed recurrent unilateral uveitis after intravenously application of 150 ml of iopamidol for contrast-enhanced CT scans in a patient with lymphoma in remission.
Conclusions:
Iopamidol may induce uveitis under certain circumstances. We suggest a coincidence of immunologic mechanisms with predisposing discrete vascular radiation damage.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Radiological Investigation I: X-ray and CT
Imaging Studies III: Computed Tomography
Imaging Studies V: Intravenous Urography and Retrograde Pyelography

